{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T03:01:07Z","timestamp":1755226867479,"version":"3.43.0"},"reference-count":35,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/S017968\/1","MR\/T041285\/1"],"award-info":[{"award-number":["MR\/S017968\/1","MR\/T041285\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SZCZES18Y7","SZCZES22A0-LAD"],"award-info":[{"award-number":["SZCZES18Y7","SZCZES22A0-LAD"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL141286"],"award-info":[{"award-number":["R01 HL141286"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,2,17]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Target trial emulation is a framework for evaluating the effects of treatments using observational data. The trial emulation approach involves specifying key elements of a protocol for a target trial (a randomised controlled trial designed to address the question of interest) and then describing how best to emulate the trial using observational data. Recent years have seen an uptake of target trial emulation in several disease areas, although there are limited examples in cystic fibrosis (CF). This protocol describes a study which aims to assess the applicability of target trial emulation in CF. We aim to emulate an existing trial in CF and assess to what extent the results from the trial can be replicated using registry data.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods and analysis<\/jats:title>\n<jats:p>The target trial is a published randomised controlled trial which found evidence for beneficial effects of azithromycin use on lung function in young adults with CF. Two emulated trials are planned: one using data from the UK CF Registry and one using data from the US CF Registry. The inclusion and exclusion criteria, treatment and outcome definitions, follow-up period, and estimand of interest are all designed to match the published trial as closely as possible. The analysis step of the trial emulations will use causal inference methods to control for confounding. Results obtained in the emulated trials using registry data will be compared with those from the target trial.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Ethics and dissemination<\/jats:title>\n<jats:p>Ethical approval has been granted by the London School of Hygiene and Tropical Medicine Ethics Committee (Ref: 29609). This study has also been approved by the UK CF Registry Research Committee and the North Star Review Board. The results of this study will be published in a peer-reviewed journal and presented at relevant scientific conferences.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/bmjopen-2024-091357","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T23:47:33Z","timestamp":1743032853000},"page":"e091357","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-1467","authenticated-orcid":false,"given":"Emily","family":"Granger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Todd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1887-9311","authenticated-orcid":false,"given":"Susan Christine","family":"Charman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwyneth","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Mayer","family":"Hamblett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Naehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josh","family":"Ostrenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-8051","authenticated-orcid":false,"given":"Sanja","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda","family":"Szczesniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"2025040100173337000_15.3.e091357.1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"2025040100173337000_15.3.e091357.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01586-2020"},{"key":"2025040100173337000_15.3.e091357.3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020050682"},{"key":"2025040100173337000_15.3.e091357.4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ije\/dyv295","article-title":"Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy","volume":"45","author":"Cain","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2025040100173337000_15.3.e091357.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0287-2"},{"key":"2025040100173337000_15.3.e091357.6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2287"},{"key":"2025040100173337000_15.3.e091357.7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/M21-3256","article-title":"COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System: A Target Trial Emulation Study","volume":"175","author":"Ioannou","year":"2022","journal-title":"Ann Intern Med"},{"key":"2025040100173337000_15.3.e091357.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.4221"},{"key":"2025040100173337000_15.3.e091357.9","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac098"},{"key":"2025040100173337000_15.3.e091357.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.08.040"},{"key":"2025040100173337000_15.3.e091357.11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1513\/AnnalsATS.201903-241OC","article-title":"Emulating a Novel Clinical Trial Using Existing Observational Data. Predicting Results of the PreVent Study","volume":"16","author":"Admon","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2025040100173337000_15.3.e091357.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812405"},{"key":"2025040100173337000_15.3.e091357.13","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00170-2022"},{"key":"2025040100173337000_15.3.e091357.14","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220031"},{"key":"2025040100173337000_15.3.e091357.15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pds.5507","article-title":"HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE\/ISPOR task force","volume":"32","author":"Wang","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025040100173337000_15.3.e091357.16","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.057950"},{"key":"2025040100173337000_15.3.e091357.17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx196"},{"key":"2025040100173337000_15.3.e091357.18","unstructured":"Cystic fibrosis trust . Cystic fibrosis trust homepage. Available: https:\/\/www.cysticfibrosis.org.uk\/ [Accessed 5 Jul 2023]."},{"key":"2025040100173337000_15.3.e091357.19","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-781OC"},{"key":"2025040100173337000_15.3.e091357.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.02.009"},{"key":"2025040100173337000_15.3.e091357.21","unstructured":"Cystic fibrosis foundation . Cystic fibrosis foundation homepage. Available: https:\/\/www.cff.org\/ [Accessed 5 Jul 2023]."},{"key":"2025040100173337000_15.3.e091357.22","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.3.212"},{"key":"2025040100173337000_15.3.e091357.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11081-6"},{"key":"2025040100173337000_15.3.e091357.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1749"},{"key":"2025040100173337000_15.3.e091357.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2025040100173337000_15.3.e091357.26","unstructured":"World Health Organisation . BMI-for-age (5-19 years). 2021. Available: www.who.int.https:\/\/www.who.int\/toolkits\/growth-reference-data-for-5to19-years\/indicators\/bmi-for-age [Accessed 6 Jul 2023]."},{"key":"2025040100173337000_15.3.e091357.27","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X211027181"},{"key":"2025040100173337000_15.3.e091357.28","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/aje\/kwab207","article-title":"AIPW: An R Package for Augmented Inverse Probability-Weighted Estimation of Average Causal Effects","volume":"190","author":"Zhong","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2025040100173337000_15.3.e091357.29","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2025040100173337000_15.3.e091357.30","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025040100173337000_15.3.e091357.31","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1983.127.6.725"},{"key":"2025040100173337000_15.3.e091357.32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ppul.23751","article-title":"Comparison of FEV1 reference equations for evaluating a cystic fibrosis therapeutic intervention","volume":"52","author":"Konstan","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2025040100173337000_15.3.e091357.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.08.028"},{"key":"2025040100173337000_15.3.e091357.34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jclinepi.2021.09.026","article-title":"Causal analyses of existing databases: the importance of understanding what can be achieved with your data before analysis (commentary on Hern\u00e1n)","volume":"142","author":"Morris","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"2025040100173337000_15.3.e091357.35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jclinepi.2021.09.024","article-title":"Sample size considerations are needed for the causal analyses of existing databases","volume":"141","author":"Mansournia","year":"2022","journal-title":"J Clin Epidemiol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-091357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T12:34:45Z","timestamp":1743597285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-091357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,25]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-091357"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-091357","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}